| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Disease Monitoring In Multiple Myeloma
|
Hillengass, Jens
|
|
|
23 |
4 |
p. 244-248
|
article
|
| 2 |
Editorial Board
|
|
|
|
23 |
4 |
p. A4-A5
|
article
|
| 3 |
Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective Analysis
|
Shank, B.R.
|
|
|
23 |
4 |
p. 279-290
|
article
|
| 4 |
Retrospective Review of Outcomes of Multiple Myeloma (MM) Patients With COVID-19 Infection (Two-Center Study)
|
Ehsan, Hamid
|
|
|
23 |
4 |
p. 273-278
|
article
|
| 5 |
SOHO State of the Art Updates and Next Questions | Hyper-CVAD in 2022: Lessons Learned and New Approaches
|
Rausch, Caitlin R.
|
|
|
23 |
4 |
p. 238-243
|
article
|
| 6 |
SOHO State of the Art Updates and Next Questions: New Targetable Pathways in Chronic Lymphocytic Leukemia
|
Fakhri, Bita
|
|
|
23 |
4 |
p. 232-237
|
article
|
| 7 |
SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis
|
Chifotides, Helen T.
|
|
|
23 |
4 |
p. 219-231
|
article
|
| 8 |
Table of Contents
|
|
|
|
23 |
4 |
p. A7-A8
|
article
|
| 9 |
The Dynamics of Financial Toxicity in Multiple Myeloma
|
Fiala, Mark A.
|
|
|
23 |
4 |
p. 266-272
|
article
|
| 10 |
Total Body Irradiation Versus Chemotherapy Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis
|
Rehman, Mohammad Ebad Ur
|
|
|
23 |
4 |
p. 249-258
|
article
|
| 11 |
Whole-Exome Sequencing Revealed the Mutational Profiles of Primary Central Nervous System Lymphoma
|
Zhang, Rui
|
|
|
23 |
4 |
p. 291-302
|
article
|
| 12 |
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas
|
Alhaj Moustafa, Muhamad
|
|
|
23 |
4 |
p. 259-265
|
article
|
Journal description